A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2024.11.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Wenjing Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Institute of Reproductive Medic…. Hauptthemen laut MEDLINE: ADAMTS13 Protein, von Willebrand Factor, Complement Factor H, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Takeda Pharmaceutical Company, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
BACKGROUND: A loss-of-functional mutation (W1183R) in human complement factor H (CFH) is associated with complement-associated hemolytic uremic syndrome; mice carrying a similar mutation (W1206R) in CFH also develop thrombotic microangiopathy but its plasma von Willebrand factor (VWF) multimer sizes were dramatically reduced. The mechanism underlying such a dramatic change in plasma VWF multimer distribution in these mice is not fully understood. OBJECTIVES: To determine the VWF and CFH interaction and how CFH proteins affect VWF multimer distribution. METHODS: We employed recombinant protein expression, purification, and various biochemical and biophysical tools. RESULTS: Purified recombinant W1183R-CFH but not wild-type (WT) CFH protein enhanced the proteolytic cleavage of both peptidyl and multimeric VWF substrates by recombinant ADAMTS-13 in a concentration-dependent manner. Microscale thermophoresis assay demonstrated that both W1183R-CFH and WT-CFH proteins bound various VWF fragments (eg, AIM-A1, A1-A2-A3, D'D3, D'D3-A1, and D'D3-A1-A2) with high affinities. Optical tweezer experiments further showed a concentration-dependent alteration in the contour length (Lc) and the persistent length (Lp) following pulling VWF-A2 domain in the presence of W1183R-CFH or WT-CFH protein. AlphaFold experiments revealed conformational changes in the VWF-A2, particularly the central region where the cleavage bond resides following addition of W1183R-CFH or WT-CFH protein. CONCLUSION: These results demonstrate for the first time that W1183R-CFH but not WT-CFH protein enhances the proteolytic cleavage of VWF by ADAMTS-13 under shear. This may be achieved by mechanic-induced conformational changes of the central A2 domain, leading to an enhanced cleavage of Tyr1605-Met1606 bond by ADAMTS-13 under pathophysiological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Institute of Reproductive Medicine and Developmental Sciences, The University of Kansas Medical Cente…
- Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.
- Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA. Electronic address: frank.zhang@umass.edu.
Förderung
- NHLBI NIH HHS
- Takeda Pharmaceutical Company
- National Heart Lung and Blood Institute
Zitieren
APA
Cao, W., Liu, Y., Zhang, X. F., & Zheng, X. L. (2025). A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.11.031
Vancouver
Cao W, Liu Y, Zhang XF, Zheng XL. A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.11.031
BibTeX
@article{Cao2025,
author = {Cao, Wenjing and Liu, Yi and Zhang, X Frank and Zheng, X Long},
title = {A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2024.11.031}
}
EUVIMED